Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol

Fertility and Sterility

Volumn 89, Issue 4, 2008, Pages 966-973

  Batukan, Cem ^a   Ozgun, Mahmut T ^a   Ozcelik, Bulent ^a   Aygen, Ercan ^a   Sahin, Yilmaz ^a   Turkyilmaz, Cagdas ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

cervical ripening; hysteroscopy; Misoprostol; oral; premenopause; vaginal

Indexed keywords

MISOPROSTOL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOMETRIUM POLYP; ENDOSCOPIC SURGERY; FEMALE; HUMAN; HYSTEROSCOPY; MAJOR CLINICAL STUDY; MUSCLE CRAMP; MYOMA; NAUSEA; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TREATMENT DURATION; UTERINE CERVIX; UTERINE CERVIX DILATATION; UTERINE CERVIX DISEASE; UTERUS BLEEDING; UTERUS PERFORATION; VOMITING;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; CERVICAL RIPENING; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYSTEROSCOPY; LABOR STAGE, FIRST; MISOPROSTOL; OXYTOCICS; PREGNANCY; PREMENOPAUSE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UTERINE PERFORATION; UTERUS;

EID: 41749089622     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.03.099     Document Type: Article

References (29)

1. Jansen F.W., Vredevoogd C.B., van Ulzen K., Hermans J., Trimbos J.B., and Trimbos-Kemper T.C. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol 96 (2000) 266-270
2. Schulz K.F., Grimes D.A., and Cates Jr. W. Measures to prevent cervical injury during suction curettage abortion. Lancet 1 (1983) 1182-1185
3. Grimes D.A., Schulz K.F., and Cates Jr. W.J. Prevention of uterine perforation during curettage abortion. JAMA 251 (1984) 2108-2111
4. Lauersen N.H., Den T., Iliescu C., Wilson K.H., and Graves Z.R. Cervical priming prior to dilatation and evacuation: a comparison of methods. Am J Obstet Gynecol 144 (1982) 890-894
5. Lokugamage A.U., Refaey H.E., and Rodeck C.H. Misoprostol and pregnancy: ever-increasing indications of effective usage. Curr Opin Obstet Gynecol 15 (2003) 513-518
6. Ngai S.W., Chan Y.M., Liu K.L., and Ho P.C. Oral misoprostol for cervical priming in non-pregnant women. Hum Reprod 12 (1997) 2373-2375
7. Preutthipan S., and Herabutya A. A randomized controlled trial of vaginal misoprostol for cervical priming before hysteroscopy. Obstet Gynecol 94 (1999) 427-430
8. Preutthipan S., and Herabutya Y. Vaginal misoprostol for cervical priming before operative hysteroscopy: a randomized controlled trial. Obstet Gynecol 96 (2000) 890-894
9. Thomas J.A., Leyland N., Durand N., and Windrim R.C. The use of oral misoprostol as a cervical ripening agent in operative hysteroscopy: a double-blind, placebo-controlled trial. Am J Obstet Gynecol 186 (2002) 876-879
10. Barcaite E., Bartusevicius A., Railaite D.R., and Nadisauskiene R. Vaginal misoprostol for cervical priming before hysteroscopy in perimenopausal and postmenopausal women. Int J Gynaecol Obstet 91 (2005) 141-145
11. Choksuchat C., Cheewadhanaraks S., Getpook C., Wootipoom V., and Dhanavoravibul K. Misoprostol for cervical ripening in non-pregnant women: a randomized double-blind controlled trial of oral versus vaginal regimens. Hum Reprod 21 (2006) 2167-2170
12. Darwish A.M., Ahmad A.M., and Mohammad A.M. Cervical priming prior to operative hysteroscopy: a randomized comparison of laminaria versus misoprostol. Hum Reprod 19 (2004) 2391-2394
13. Tang O.S., Schweer H., Seyberth H.W., Lee S.W., and Ho P.C. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 17 (2002) 332-336
14. Khan R.U., El-Refaey H., Sharma S., Sooranna D., and Stafford M. Oral, rectal, and vaginal pharmacokinetics of misoprostol. Obstet Gynecol 103 (2004) 866-870
15. Oppegaard K.S., Abdelnoor M., Nesheim B.I., Jerve F., and Eskild A. The use of oral misoprostol for pre-abortion cervical priming: a randomised controlled trial of 400 versus 200 microg in first trimester pregnancies. BJOG 111 (2004) 154-159
16. Bunnasathiansri S., Herabutya Y., and O-Prasertsawat P. Vaginal misoprostol for cervical priming before dilatation and curettage in postmenopausal women: a randomized controlled trial. J Obstet Gynaecol Res 30 (2004) 221-225
17. Yoshida M., Sagawa N., Itoh H., Yura S., Takemura M., Wada Y., et al. Prostaglandin F2 alpha, cytokines and cyclic mechanical stretch augment matrix metalloproteinase-1 secretion from cultured human uterine cervical fibroblast cells. Mol Hum Reprod 8 (2002) 681-687
18. Kelly R.W. Inflammatory mediators and cervical ripening. J Reprod Immunol 57 (2002) 217-224
19. Rath W., Osmers R., Stuhlsatz H.W., and Adelmann-Grill B.C. Biochemical principles of cervix ripening and dilatation. Z Geburtshilfe Perinatol 198 (1994) 186-195
20. el-Refaey H., Calder L., Wheatley D.N., and Templeton A. Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet 343 (1994) 1207-1209
21. Fernandez H., Alby J.D., Tournoux C., Chauveaud-Lambling A., DeTayrac R., Frydman R., et al. Vaginal misoprostol for cervical ripening before operative hysteroscopy in premenopausal women: a double-blind, placebo-controlled trial with three dose regimens. Hum Reprod 19 (2004) 1618-1621
22. Zieman M., Fong S.K., Benowitz N.L., Banskter D., and Darney P.D. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 90 (1997) 88-92
23. Cicinelli E., de Ziegler D., Bulletti C., Matteo M.G., Schonauer L.M., and Galantino P. Direct transport of progesterone from vagina to uterus. Obstet Gynecol 95 (2000) 403-406
24. Ngai S.W., Tang O.S., Lao T., Ho P.C., and Ma H.K. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy. Hum Reprod 10 (1995) 1220-1222
25. Lawrie A., Penney G., and Templeton A. A randomised comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol 103 (1996) 1117-1119
26. Cakir L., Dilbaz B., Caliskan E., Dede F.S., Dilbaz S., and Haberal A. Comparison of oral and vaginal misoprostol for cervical ripening before manual vacuum aspiration of first trimester pregnancy under local anesthesia: a randomized placebo-controlled study. Contraception 71 (2005) 337-342
27. Cooper K.G., Pinion S.B., Bhattacharya S., and Parkin D.E. The effects of the gonadotrophin releasing hormone analogue (goserelin) and prostaglandin E1 (misoprostol) on cervical resistance prior to transcervical resection of the endometrium. Br J Obstet Gynaecol 103 (1996) 375-378
28. Aronsson A., Ulfgren A.K., Stabi B., Stavreus-Evers A., and Gemzell-Danielsson K. The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy. Contraception 72 (2005) 33-39
29. Singh K., Fong Y.F., Prasad R.N., and Dong F. Vaginal misoprostol for preabortion cervical priming: is there an optimal evacuation time interval?. Br J Obstet Gynaecol 106 (1999) 266-269